|
[1] LONARDO A,BELLENTANI S,ARGO CK,et al. Epidemiological modifiers of non-alcoholic fatty liver disease:Focus on high-risk groups[J]. Dig Liver Dis,2015,47(12):997-1006.
|
|
[2] ZHAO CC,WANG AP,LI LX,et al. Urine uric acid excretion is associated with nonalcoholic fatty liver disease in patients with type 2 diabetes[J]. J Diabetes Complications,2016,30(6):1074-1080.
|
|
[3] YU L,FENG C,JIANG YM,et al. Changes and significance of homocysteine,total cholesterol and serum uric acid in patients with type 2 diabetes mellitus[J]. Clin J Med Offic,2019,47(12):1355-1356.(in Chinese)俞琳，冯晨，蒋艳敏，等．同型半胱氨酸、总胆固醇及血尿酸在2型糖尿病患者血清中变化及意义[J]．临床军医杂志，2019,47(12):1355-1356.
|
|
[4] Multi-disciplinary expert task force on hyperuricemia and its related diseases. Chinese multi-disciplinary consensus on the diagnosis and treament of hyperuricemia and its related diseases[J]. Chin J Intern Med,2017,56(3):235-248.(in Chinese)高尿酸血症相关疾病诊疗多学科共识专家组．中国高尿酸血症相关疾病诊疗多学科专家共识[J]．中华内科杂志，2017,56(3):235-248.
|
|
[5] LIN H,LI Q,LIU X,et al. Liver fat content is associated with elevated serum uric acid in the Chinese middle-aged and elderly populations:Shanghai changfeng study[J]. PLo S One,2015,10(10):e140379.
|
|
[6] CAI W,WENG DH,DONG HZ,et al. Prospective cohort study on the predictive value of serum uric acid levels to the incident nonalcoholic fatty liver disease[J]. Chin Endocrinol Metab,2017,33(3):203-207.(in Chinese)蔡雯，翁迪华，董正惠，等．血尿酸水平预测非酒精性脂肪性肝病的前瞻性队列研究[J]．中华内分泌代谢杂志，2017,33(3):203-207.
|
|
[7] ALBERTI KG,ZIMMET PZ. Definition,diagnosis and classification of diabetes mellitus and its complications. Part 1:Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J]. Diabet Med,1998,15(7):539-553.
|
|
[8] Chinese Society of Hepatology,Department of Fatty Liver and Alcoholic Liver Disease,Chinese Medical Association,Expert Committee on Fatty Liver Diseases. The guidelines of prevention and treatment for nonalcoholic fatty liver diseases(Updated 2018)[J]. J Clin Hepatol,2018,34(5):947-957.(in Chinese)中华医学会肝病学分会脂肪肝和酒精性肝病学组，中国医师协会脂肪性肝病专家委员会．非酒精性脂肪性肝病防治指南(2018年更新版)[J]．临床肝胆病杂志，2018,34(5):947-957.
|
|
[9] McPHERSON S,HARDY T,DUFOUR JF,et al. Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis[J]. Am J Gastroenterol,2017,112(5):740-751.
|
|
[10] TILG H,MOSCHEN AR. Evolution of inflammation in nonalcoholic fatty liver disease:The multiple parallel hits hypothesis[J]. Hepatology,2010,52(5):1836-1846.
|
|
[11] ANGULO P,HUI JM,MARCHESINI G,et al. The NAFLD fibrosis score:A noninvasive system that identifies liver fibrosis in patients with NAFLD[J]. Hepatology,2007,45(4):846-854.
|
|
[12] YANG LH,LIAO X,ZHANG H,et al. Relationship between liver fibrosis and serum 25-(OH)D in patients with type 2 diabetes and nonalcoholic fatty liver disease[J]. Chin J Diabetes,2018,26(2):117-122.(in Chinese)杨丽弘，廖鑫，张晗，等．2型糖尿病合并非酒精性脂肪肝肝纤维化与血清25-羟维生素D水平的关系研究[J]．中国糖尿病杂志，2018,26(2):117-122.
|
|
[13] ZHANG XE,QU S. Recognizing hyperuricemia from the viewpoint of the inflammation[J]. Chin Endocrinol Metab,2019,35(8):718-722.(in Chinese)张玄娥，曲伸．高尿酸血症的现代进化与多重性作用———从炎症角度审视高尿酸血症[J]．中华内分泌代谢杂志，2019,35(8):718-722.
|
|
[14] BALLESTRI S,NASCIMBENI F,ROMAGNOLI D,et al. The independent predictors of non-alcoholic steatohepatitis and its individual histological features. Insulin resistance,serum uric acid,metabolic syndrome,alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment[J]. Hepatol Res,2016,46(11):1074-1087.
|
|
[15] QIU JS,ZHOU ZY,ZHANG WH,et al. Uric acid induces endothelial dysfunction through inflammatory mediators in patients with type 2 diabetes mellits[J]. Chin J Immunol,2019,35(18):2267-2271.(in Chinese)邱杰山，周子英，张文华，等．2型糖尿病患者高尿酸血症与血管内皮细胞功能损伤关系的研究[J]．中国免疫学杂志，2019,35(18):2267-2271.
|
|
[16] ZHANG X,ZHANG JH,CHEN XY,et al. Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation[J]. Antioxid Redox Signal,2015,22(10):848-870.
|
|
[17] LANASPA MA,SANCHEZ-LOZADA LG,CHOI YJ,et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress:Potential role in fructose-dependent and-independent fatty liver[J]. J Biol Chem,2012,287(48):40732-40744.
|
|
[18] SANCHEZ-VALLLE V,CHAVEZ-TAPIA NC,URIBE M,et al. Role of oxidative stress and molecular changes in liver fibrosis:a review[J]. Curr Med Chem,2012,19(28):4850-4860.
|
|
[19] WAN X,XU C,LIN Y,et al. Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism[J]. J Hepatol,2016,64(4):925-932.
|
|
[20] ZAHO J,QI YF,YU YR. Research advances in the role of oxidative stress in the development and progression of liver fibrosis[J]. J Clin Hepatol,2019,35(9):2067-2071.(in Chinese)赵杰，齐永芬，鱼艳荣．氧化应激在肝纤维化发生发展中的作用[J]．临床肝胆病杂志，2019,35(9):2067-2071.
|
|
[21] SANDAR S,LESMANA C,PURNAMASARI D,et al. Hyperuricemia as an independent risk factor for non-alcoholic fatty liver disease(NAFLD)progression evaluated using controlled attenuation parameter-transient elastography:Lesson learnt from tertiary referral center[J]. Diabetes Metab Syndr,2019,13(1):424-428.
|
DownLoad: